NCAM1 and acute myeloid leukemia: Therefore, in our study, we retrospectively analyzed the effect of CD56 on prognosis in a large cohort of pediatric patients with AML treated at two centers of the cooperation group to evaluate the prognostic value of CD56 in childhood AML.